title: Prognostic factors and clinical trials.
abstract: The identification of prognostic factors is an important area of cancer research. This article contains an introduction to the uses of prognostic factors, statistical methods for their identification, and a summary of the literature concerning the evolution of serum beta 2 microglobulin as a prognostic factor in multiple myeloma.
authors: Department of Biomathematics MD Anderson Cancer Center.
authors: D O
authors: DO
authors: Dixon
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000378:metabolism* / Q000628:therapy; D009369:Neoplasms / Q000032:analysis* / Q000628:therapy; D011237:Predictive Value of Tests; D011379:Prognosis; D001613:beta 2-Microglobulin / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D001613:beta 2-Microglobulin